Back to top

Kepler Capital Reaffirms Their Hold Rating on Novonesis (0Q4U)

In a report released on September 9, Patrick Roquas from Kepler Capital maintained a Hold rating on Novonesis, with a price target of DKK415.00. Th...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Novozymes A/S (NVZMY)